Paediatric Sedation With Intranasal Dexmedetomidine for Magnetic Resonance Imaging
BACKGROUND: Paediatric sedation for magnetic resonance imaging presents significant challenges. To facilitate this, our department decided to implement paediatric sedation with intranasal dexmedetomidine for children requiring a scan. We aim to summarise lessons learnt from implementation of intranasal dexmedetomidine, comparing time consumption and effectiveness. METHODS: We conducted a prospective observational study. Data from children sedated with intranasal dexmedetomidine 4 μg/kg (n = 51) were collected prospectively and compared with historical controls (n = 100) collected from children previously anaesthetized with either sevoflurane or propofol. RESULTS: Sedation with intranasal dexmedetomidine resulted in a longer hospital stay (214 min vs. 133 min [67.94-94.74]), longer time to sufficient sedation (60 min vs. 26 min [29.31, 38.68]) and longer time in the post-operative unit (112 min vs. 64, 48 min [36.11, 60, 80]). Of children sedated with dexmedetomidine, 75% were cooperative with the intranasal administration of the medicine and 37% were successfully sedated with dexmedetomidine as the sole sedative. In the historical controls, 43% of patients required airway management compared to 1.9% in the dexmedetomidine group [0.00, 0.19]. In the control group, 20% had post-sedation agitation compared to none in the dexmedetomidine group. No serious bradycardia or desaturation was registered in either group. CONCLUSION: Paediatric sedation with intranasal dexmedetomidine as the sole medicament for magnetic resonance imaging is more time-consuming compared to sevoflurane and propofol. Sedation with intranasal dexmedetomidine has a relatively low success rate but is without serious adverse events. EDITORIAL COMMENT: This single center case-control study with prospective datacollection for the case group, intranasal dexmedetomidine and comparison with a historical non-dexmedetomidine sedation group described multiple possible clinical advantages with intranasal dexmedetomidine administration as it was done here.
Authors
- Sofie Ronja Petersen (ORCID: https://orcid.org/0000-0001-6177-8930)
- Rajesh Prabhakar Bhavsar (ORCID: https://orcid.org/0000-0001-5747-5769)
- Katrine Dueholm Nissen (ORCID: https://orcid.org/0009-0001-0491-3005)
- Thomas Strøm (ORCID: https://orcid.org/0000-0002-1868-0978)
- Caroline Margaret Moos (ORCID: https://orcid.org/0000-0003-4997-4319)
- Andras Wolf
- Jeppe Keller
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Sygehus Sønderjylland (DK)
Publication Details
- Journal
- Acta Anaesthesiologica Scandinavica
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1111/aas.70398
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00